Learn more

LEGOCHEM BIOSCIENCE LTD

Overview
  • Total Patents
    38
  • GoodIP Patent Rank
    207,039
About

LEGOCHEM BIOSCIENCE LTD has a total of 38 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Chile. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NANTBIOSCIENCE INC, CHEMBRIDGE CORP and FARMAK INTERNAT HOLDING GMBH.

Patent filings per year

Chart showing LEGOCHEM BIOSCIENCE LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Woo Sung Ho 36
#2 Kim Yong Zu 36
#3 Park Tae Kyo 35
#4 Lee Hyang Sook 30
#5 Chae Sang Eun 26
#6 Cho Young Lag 25
#7 Baek Sung Yoon 22
#8 Song Ho Young 21
#9 Lee Dae Yon 16
#10 Kim Yeon Ok 14

Latest patents

Publication Filing date Title
KR20150137015A Compounds comprising self-immolative group
KR20150136294A New Compound Having Inhibition Activity to Factor XIa
KR20140085965A Method for preparing (2-methyl-1-(3-methylbenzyl)-1H-benzo[d]imidazol-5-yl)(piperidin-1-yl)methanone
KR20120081579A Novel oxazolidinone derivatives with cyclic amidrazone and pharmaceutical compositions thereof
KR20130131775A Dipeptide derivatives having inhibition activity to factor xia
KR20120110600A Novel oxazolidinone derivatives and pharmaceutical compositions comprising the same
KR20120110625A Novel cephalosporin derivatives and pharmaceutical compositions comprising the same
KR20120109667A Novel compounds of inhibiting activity of heat shock protein
KR20120108181A Mitochondriotropic anticancer agents of inhibiting heat shock protein 90 (hsp90)
KR20110101499A Method for preparing of (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives
KR20110088737A Novel oxazolidinone derivatives with cyclic amidrazone and pharmaceutical compositions thereof
KR20110004590A Method for preparing 5-chloro-n-(((5s)-2-oxo-3-(4-(5,6-dihydro-1,2,4-triazin-1(4h)-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophen-2-carboxamide derivatives, and their intermediates
KR20110004610A Method for preparing of (s)-5-chloro-n-((3-(4-(5,6-dihydro-4h-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives
KR20100034522A Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
KR100898361B1 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
WO2008140220A1 Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
KR20080099803A Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
WO2008069619A1 Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same
KR20080053209A Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same
KR20080077828A Novel oxazolidinones with amidoxime or hydroxamide and pharmaceutical compositions and derivatives thereof